Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • 6 international mutual funds reopen for lump sum, SIPs: Should you invest now? – Money News
    • Templeton launches global equity fund
    • AI ETFs Explained: What Investors Should Know Before Buying
    • How Much of Your Portfolio Should Be in Thematic ETFs?
    • Morningstar’s Top Fund Picks for a Simpler Retirement Plan
    • India’s Specialized Investment Fund Segment Set to Grow with Mahindra Manulife’s Equity Long-Short Fund Launch
    • Bitcoin ETFs Extend Win Streak to 9 Days, Matching August Rally
    • 5 Best Money Market Funds for 2026 and How to Invest
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Mutual Funds»HDFC Pharma & Healthcare Fund Delivers 30.19% CAGR, Scheme Bets On India’s Expanding Healthcare Sector
    Mutual Funds

    HDFC Pharma & Healthcare Fund Delivers 30.19% CAGR, Scheme Bets On India’s Expanding Healthcare Sector

    September 8, 2026


    Mumbai: has highlighted the performance of its HDFC Pharma and Healthcare Fund, which delivered a compound annual growth rate of 30.19 percent since its launch on October 4, 2023.

    The sectoral fund also generated a one-year return of 19.01 percent as of July 31, 2026. Its net asset value stood at Rs 21.069 on the same date.

    Where does the fund invest?

    The scheme aims to generate long-term capital appreciation by investing mainly in equity and equity-related instruments of pharmaceutical and healthcare companies.

    Its portfolio covers , healthcare service providers, biotechnology, medical equipment and supplies. The fund follows a research-led, bottom-up investment approach and can invest across companies of different market capitalisations.

    Nikhil Mathur manages the HDFC Pharma and Healthcare Fund.

    Healthcare growth opportunity

    HDFC Mutual Fund said India’s pharmaceutical and healthcare industry offers a structural growth opportunity, supported by rising domestic demand, increasing healthcare expenditure and expanding export opportunities.

    India’s position as a major global pharmaceutical manufacturing centre is also expected to support the sector’s long-term prospects.

    The fund house sees opportunities in complex generic medicines, biosimilars, speciality drugs, contract development and manufacturing, hospitals, diagnostics and medical technology.

    Long-term trends support demand

    An ageing population, the growing incidence of lifestyle-related diseases, rising per capita income and increasing health insurance penetration could further boost healthcare spending in India.

    HDFC AMC Managing Director and Chief Executive Officer Navneet Munot said the fund house remains focused on identifying businesses that are well placed to benefit from these long-term trends.

    However, investors should note that sectoral and thematic schemes carry higher risks than diversified equity mutual funds because their investments are concentrated in a particular sector or theme.

    Past performance may not continue in the future and does not guarantee future returns. Investors should carefully assess their risk appetite and financial goals before investing.




    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    6 international mutual funds reopen for lump sum, SIPs: Should you invest now? – Money News

    September 30, 2026

    Templeton launches global equity fund

    September 30, 2026

    India’s Specialized Investment Fund Segment Set to Grow with Mahindra Manulife’s Equity Long-Short Fund Launch

    September 30, 2026
    Leave A Reply Cancel Reply

    Top Posts

    Purpose Investments Inc. Announces 2026 Third Quarter Distributions for Purpose Specialty Lending Trust

    September 30, 2026

    7 Best Money Market Funds to Buy for 2026 | Investing

    July 9, 2026

    Wall Street Now Sells 11 Weekly-Pay ETFs. Only Three Have Beaten the S&P. Here They Are

    September 30, 2026

    Morningstar’s Top Fund Picks for a Simpler Retirement Plan

    September 30, 2026
    Don't Miss
    Mutual Funds

    6 international mutual funds reopen for lump sum, SIPs: Should you invest now? – Money News

    September 30, 2026

    For lump sum and SIP investments, several international mutual funds are reopening to Indian investors. …

    Templeton launches global equity fund

    September 30, 2026

    AI ETFs Explained: What Investors Should Know Before Buying

    September 30, 2026

    How Much of Your Portfolio Should Be in Thematic ETFs?

    September 30, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    McKinney council members approve $126.4M bond issuance for city projects

    July 11, 2024

    Akasa Air completes strategic investments; Premji Invest, 360 ONE Asset, Claypond now on board

    August 19, 2025

    What is Claude AI and who funds it?

    September 11, 2025
    Our Picks

    6 international mutual funds reopen for lump sum, SIPs: Should you invest now? – Money News

    September 30, 2026

    Templeton launches global equity fund

    September 30, 2026

    AI ETFs Explained: What Investors Should Know Before Buying

    September 30, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    🇮🇸 CPP Investments and Equinix complete atNorth acquisition to support growth of leading Nordic data center platform

    September 1, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.